Citas bibligráficas
Villanueva, J., Santisteban, E. (2023). Asociación entre el uso de antihipertensivos y la obesidad en consumidores del mercado modelo en Chiclayo – Lambayeque, 2022. [Universidad Privada de Huancayo Franklin Roosevelt]. http://repositorio.uroosevelt.edu.pe/handle/20.500.14140/1525
Villanueva, J., Santisteban, E. Asociación entre el uso de antihipertensivos y la obesidad en consumidores del mercado modelo en Chiclayo – Lambayeque, 2022. []. PE: Universidad Privada de Huancayo Franklin Roosevelt; 2023. http://repositorio.uroosevelt.edu.pe/handle/20.500.14140/1525
@misc{renati/691499,
title = "Asociación entre el uso de antihipertensivos y la obesidad en consumidores del mercado modelo en Chiclayo – Lambayeque, 2022.",
author = "Santisteban Sanchez, Erika Del Rocio",
publisher = "Universidad Privada de Huancayo Franklin Roosevelt",
year = "2023"
}
The general objective of this research was to identify the association between the use of antihypertensive drugs and obesity in consumers of the Modelo market in Chiclayo - Lambayeque 2022, it is a non-experimental, cross-sectional, analytical correlational, observational, representative sample will be 100 consumers. The prevalence of the use of antihypertensive drugs is 82%. The most used antihypertensives are Losartan (39%), the time of consumption of antihypertensives is 56.1% from 1 to 5 years, the frequency of consumption is daily in 87.8% and the doses used per day are 1 in 58.5%, prevalence of obesity is 70%. There is a significant statistical relationship (p = 0.01) between the use of antihypertensive drugs and obesity in consumers of the Modelo market of Chiclayo - Lambayeque, 2022.
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons